tiprankstipranks
Trending News
More News >
Bausch + Lomb price reaction to recall ‘likely overdone,’ says RBC Capital
PremiumThe FlyBausch + Lomb price reaction to recall ‘likely overdone,’ says RBC Capital
19d ago
BofA sees Bausch + Lomb IOL recall news as positive for RxSight
Premium
The Fly
BofA sees Bausch + Lomb IOL recall news as positive for RxSight
20d ago
Bausch + Lomb Initiates Voluntary Recall of enVista Intraocular Lenses
Premium
Company Announcements
Bausch + Lomb Initiates Voluntary Recall of enVista Intraocular Lenses
20d ago
Bausch + Lomb Unveils Arise Orthokeratology Lens System in the U.S.
PremiumCompany AnnouncementsBausch + Lomb Unveils Arise Orthokeratology Lens System in the U.S.
30d ago
Bausch + Lomb announces U.S. launch of lens fitting system Arise for Ortho-k
Premium
The Fly
Bausch + Lomb announces U.S. launch of lens fitting system Arise for Ortho-k
30d ago
Bausch + Lomb price target lowered to $18 from $19 at Morgan Stanley
Premium
The Fly
Bausch + Lomb price target lowered to $18 from $19 at Morgan Stanley
2M ago
Bausch + Lomb Corporation: Sell Rating Due to Limited Growth Prospects and Strategic Challenges
PremiumRatingsBausch + Lomb Corporation: Sell Rating Due to Limited Growth Prospects and Strategic Challenges
2M ago
Bausch + Lomb Reports Growth Amidst Revenue Challenges
Premium
Company Announcements
Bausch + Lomb Reports Growth Amidst Revenue Challenges
2M ago
Bausch + Lomb price target lowered to $17 from $18 at JPMorgan
Premium
The Fly
Bausch + Lomb price target lowered to $17 from $18 at JPMorgan
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100